Whilst

Whilst

trimetazidine

Manufacturer:

ACME

Distributor:

Euro Generics

Marketer:

D'Conner Pharma
Concise Prescribing Info
Contents
Trimetazidine HCl
Indications/Uses
Add-on therapy for the symptomatic treatment of stable angina pectoris in adult patients who are inadequately controlled by or intolerant to 1st-line anti-anginal therapies.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Parkinson's disease, parkinsonian symptoms, tremors, restless leg syndrome & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Not a curative treatment for angina attacks, nor initial treatment for unstable angina or MI, nor in the pre-hospital phase or during the 1st days of hospitalization. May cause or worsen parkinsonian symptoms (tremor, akinesia, hypertonia). Discontinue use in the occurrence of movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, gait instability. Falls may occur, related to gait instability or hypotension particularly in patients on antihypertensive treatment. Moderate renal impairment. Pregnancy & lactation. Childn <18 yr. Elderly >75 yr.
Adverse Reactions
Dizziness, headache, GI disorders (eg, abdominal pain, diarrhea, dyspepsia, nausea & vomiting), rashes, pruritus, urticaria & asthenia.
MIMS Class
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Whilst MR tab 35 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in